Lifesaving medicines such as treatments for cardiovascular disease and HIV and AIDS are often not accessible because of the cost to patients, among other reasons.
1 Global estimates of medication nonadherence are between 40% and 60% for treatments for chronic diseases.
2 A systematic review of interventions to improve adherence identified few effective interventions and underscored the need for additional high-quality studies.
3 Providing certain medicines at no charge for people with specific conditions such as myocardial infarction, hypertension, HIV and AIDS, and schizophrenia can improve surrogate and direct health measures related to those conditions.
4-7 The World Health Organization recommends that countries develop a list of essential medicines “that satisfy the priority health care needs of the population” for the purpose of increasing access and quality of care, and facilitating medicine access is one way to help achieve universal health coverage.
8